View More View Less
  • 1 First Department of Medicine, Medical Faculty, University of Pécs Ifjúság út 13, H-7624 Pécs, Hungary
  • | 2 Division of Virology, “Johan Béla” National Center for Epidemiology Gyáli út 2-6, H-1097 Budapest, Hungary
  • | 3 Division of Virology, “Johan Béla” National Center for Epidemiology Gyáli út 2-6, H-1097 Budapest, Hungary
  • | 4 Division of Virology, “Johan Béla” National Center for Epidemiology Gyáli út 2-6, H-1097 Budapest, Hungary
  • | 5 Blood Transfusion Centre Dischka u. 7, H-7621 Pécs, Hungary
  • | 6 National Medical Center Szabolcs u. 35, H-1135 Budapest, Hungary
  • | 7 Department of Clinical Chemistry, Medical Faculty University of Pécs, Ifjúság út 13, H-7624 Pécs, Hungary
  • | 8 Department of Pathology, Baranya County Hospital Rákóczi u. 2, H-7621 Pécs, Hungary
  • | 9 First Department of Medicine, Medical Faculty, University of Pécs Ifjúság út 13, H-7624 Pécs, Hungary
  • | 10 First Department of Medicine, Medical Faculty, University of Pécs Ifjúság út 13, H-7624 Pécs, Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The significance of co-infections with novel hepatitis viruses Hepatitis G (GBV-C, HGV) and TT virus (TTV) in chronic hepatitis C is not clear. We determined the prevalence of HGV RNA and TTV DNA in chronic hepatitis C patients and in asymptomatic hepatitis C virus (HCV) carriers, and assessed the influence of these agents on the course of HCV infection.  Seventy-seven patients with chronic hepatitis C - 50 of them treated with interferon (IFN) - and 33 HCV carriers with normal alanine aminotransferase have been investigated. Previous HBV infection was detected by testing serum HBsAg and aHBc. HGV RNA and TTV DNA were detected by PCR. In the healthy population, the prevalence of anti-HCV was 0.3%, HGV RNA 8.0% and TTV DNA 18.5%. In chronic hepatitis C HGV RNA occurred in 9.09% and TTV DNA in 40.25% of cases. In IFN-treated patients with sustained remission, the frequency of TTV was 20% vs. 45.7% found in non-responders. Among asymptomatic HCV-carriers, the prevalence of HGV RNA was 9.09% and TTV DNA 75.7%. Neither HGV RNA nor TTV DNA had apparent effect on the HCV infection. TTV was detected with the lowest frequency in persons with sustained remission due to IFN, suggesting antiviral effect of IFN on TTV.

  • Thomas, D. L., Astenborski, D., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N.: Natural history of hepatitis C virus infection. Host, viral and environmental factors. JAMA284, 480-486 (2000).

    'Natural history of hepatitis C virus infection. Host, viral and environmental factors ' () 284 JAMA : 480 -486.

    • Search Google Scholar
  • Simons, J. N., Leary, T. P., Dawson, G. J., Pilot-Matias, T. J., Muerhoff, A. S., Schlauder, G. G., Desai, S. M., Mushawar, I. K.: Isolation of novel virus-like sequences associated with human hepatitis. Nat Med1, 564-569 (1995).

    'Isolation of novel virus-like sequences associated with human hepatitis ' () 1 Nat Med : 564 -569.

    • Search Google Scholar
  • Linnen, J., Wages, Jr. J., Zhang-Keck, Z. Y., Fry, K. E., Krawczynski, K. Z., Alter, H., Koonin, E., Gallagher, M., Alter, M., Hadziyannis, S., Karayannis, P., Fyng, K., Nakatsuji, Y., Shih, J. W., Young, L., Piatak, M., Hoover, C., Fernandez, J., Chen, S., Zou, J. C., Morris, T., Hyams, K. C., Ismay, S., Lifson, J. D., Hess, G., Foung, S. K., Thomas, H., Bradley, D., Margolis, H., Kim, J. P.: Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science271, 505-508 (1996).

    'Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent ' () 271 Science : 505 -508.

    • Search Google Scholar
  • Halasz, R., Weiland, O., Sallberg, M.: GB virus C/ hepatitis G virus. Scand J Infect Dis33, 572-580 (2001).

    'GB virus C/ hepatitis G virus ' () 33 Scand J Infect Dis : 572 -580.

  • Saiz, J. C., Ampurdanés, S., Olmedo, E., Lopez-Labrador, F. X., Forns, X., Guilera, M., Tassies, D., Costa, J., Sanchez-Tapias, J. M., Jimenez de Anta, M. T., Rodes, J.: Hepatitis G virus infection in chronic hepatitis C frequency, features and response to interferon therapy. J Hepatol26, 787-793 (1997).

    'Hepatitis G virus infection in chronic hepatitis C frequency, features and response to interferon therapy ' () 26 J Hepatol : 787 -793.

    • Search Google Scholar
  • Nishizawa, T., Okamoto, H., Konishi, K., Yoshizawa, H., Miyakawa, Y., Mayumi, M.: A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Comm241, 992-997 (1997).

    'A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology ' () 241 Biochem Biophys Res Comm : 992 -997.

    • Search Google Scholar
  • Ikeda, H., Takasu, M., Inoue, K., Okamoto, H., Miyakawa, Y., Mayumi, M:. Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for HCV RNA. J Hepatol30, 205-212 (1999).

    'Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for HCV RNA ' () 30 J Hepatol : 205 -212.

    • Search Google Scholar
  • Pawlotsky, J. M., Dhumeaux, D.: The G virus the orphan virus (In French). Press Med28, 1882-1883 (1999).

    'The G virus the orphan virus (In French) ' () 28 Press Med : 1882 -1883.

  • Nordbo, S. A., Krokstad, S., Winge, P., Skjeldestad, F. E., Dalen, A. B.: Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors. J Clin Microbiol38, 2584-2590 (2000).

    'Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors ' () 38 J Clin Microbiol : 2584 -2590.

    • Search Google Scholar
  • Bjorkman, P., Widell, A., Veress, B., Verbaan, H., Hoffmann, G., Elmstahl, S., Lindgren, S.: GB virus C/HGV infection in patients investigated for chronic liver disease and in the general population in southern Sweden. Scand J Infect Dis33, 611-617 (2001).

    'GB virus C/HGV infection in patients investigated for chronic liver disease and in the general population in southern Sweden ' () 33 Scand J Infect Dis : 611 -617.

    • Search Google Scholar
  • Hayashi, J., Ueno, K., Kawakami, Y., Kishihara, Y., Ariyama, I., Furusyo, N., Sawayama, Y., Etoh, Y., Kashiwagi, S.: Clinical course of chronic hepatitis C virus infection is not influenced by concurrent hepatitis G virus infection. Dig Dis Sci44, 618-623 (1999).

    'Clinical course of chronic hepatitis C virus infection is not influenced by concurrent hepatitis G virus infection ' () 44 Dig Dis Sci : 618 -623.

    • Search Google Scholar
  • Radkowski, M., Kubicka, J., Kisiel, E., Ciaciara, J., Nowicki, M., Rakela, J., Laskus, T.: Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood95, 3986-3989 (2000).

    'Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects ' () 95 Blood : 3986 -3989.

    • Search Google Scholar
  • Strauss, E., de Costa Gayotti, L. C., Fay, F., Fay, O., Fernandes, H. S., Fischer Chamone, De A.: Liver histology in co-infection of hepatitis C virus (HCV) and hepatitis G virus (HGV). Rev Inst Med Trop Sao Paolo44, 67-70 (2002).

    'Liver histology in co-infection of hepatitis C virus (HCV) and hepatitis G virus (HGV) ' () 44 Rev Inst Med Trop Sao Paolo : 67 -70.

    • Search Google Scholar
  • Okamoto, H., Akahane, Y., Ukita, M., Fukuda, M., Tsuda, F., Miyakawa, Y.: Fecal excretion of a nonenveloped DNA virus (TTV) associated with post-transfusion non-A-G hepatitis. J Med Virol56, 128-132 (1998).

    'Fecal excretion of a nonenveloped DNA virus (TTV) associated with post-transfusion non-A-G hepatitis ' () 56 J Med Virol : 128 -132.

    • Search Google Scholar
  • Naumov, N. V.: TT virus - highly prevalent, but still in search of a disease. J Hepatol33, 157-159 (2000).

    'TT virus - highly prevalent, but still in search of a disease ' () 33 J Hepatol : 157 -159.

    • Search Google Scholar
  • Ikeuchi, T., Yokosuka, O., Kanda, T., Imazeki, F., Seta, T., Saisho, H.: Roles of TT virus infection in various types of chronic hepatitis. Intervirology44, 219-223 (2001).

    'Roles of TT virus infection in various types of chronic hepatitis ' () 44 Intervirology : 219 -223.

    • Search Google Scholar
  • Mizokami, M., Albrecht, J. K., Kato, T., Orito, E., Lai, V. C. H., Goodman, Z., Hong, Z., Lau, J. Y.: TT virus infection in patients with chronic hepatitis C virus infection - effects of primers, prevalence and clinical significance. J Hepatol332, 339-343 (2000).

    'TT virus infection in patients with chronic hepatitis C virus infection - effects of primers, prevalence and clinical significance ' () 332 J Hepatol : 339 -343.

    • Search Google Scholar
  • Takács, M., Szomor, K., Szendröi, A., Dencs, Á., Brojnás, J., Rusvai, E., Berencsi, Gy.: Prevalence of GBV-C/HGV in Hungary. FEMS Immunol. Med Microbiol34, 283-287 (2002).

    'Prevalence of GBV-C/HGV in Hungary. FEMS Immunol ' () 34 Med Microbiol : 283 -287.

  • Tellier, R., Bukh, J., Emerson, S. U., Miller, R. H., Purcell, R. H.: Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes. J Clin Microbiol34, 3085-3091 (1996).

    'Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes ' () 34 J Clin Microbiol : 3085 -3091.

    • Search Google Scholar
  • Khudyakov, Y. E., Cong, M. E., Bonafonte, M. T., Abdulmalek, S., Nichols, B. L., Lambert, S., Alter, M. J., Fields, H. A.: Sequence variation within a nonstructural region of the hepatitis G virus genome. J Virology71, 6875-6880 (1997).

    'Sequence variation within a nonstructural region of the hepatitis G virus genome ' () 71 J Virology : 6875 -6880.

    • Search Google Scholar
  • Moriyama, M., Matsumura, H., Shimizu, T., Shioda, A., Kaneko, M., Saito, H., Miyazawa, K., Tanaka, N., Sugitani, M., Komiyama, K., Arakawa, Y.: Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C. Liver20, 397-404 (2000).

    'Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C ' () 20 Liver : 397 -404.

    • Search Google Scholar
  • Watanabe, H., Saito, T., Kawamata, O., Shao, L., Aoki, M., Terui, Y., Mitsuhashi, H., Matsuo, T., Takeda, Y., Saito, K., Togashi, H., Shinzawa, H., Takahashi, T.: Clinical implications of TT virus superinfection in patients with chronic hepatitis C. Amer J Gastroenterol95, 1776-1780 (2000).

    'Clinical implications of TT virus superinfection in patients with chronic hepatitis C ' () 95 Amer J Gastroenterol : 1776 -1780.

    • Search Google Scholar
  • Akahane, Y., Sakamato, M., Miyazaki, Y., Okada, S., Inoune, T., Ukita, M.: Effect of interferon on non-enveloped DNA virus (TT virus) associated with acute and chronic hepatitis of unknown etiology. J Med Virol58, 196-200 (1999).

    'Effect of interferon on non-enveloped DNA virus (TT virus) associated with acute and chronic hepatitis of unknown etiology ' () 58 J Med Virol : 196 -200.

    • Search Google Scholar
  • Takács, M., Balog, K., Tóth, G., Balogh, Zs., Szomor, N. K, Brojnás, J., Rusvai, E., Minárovits, J., Berencsi, Gy.: TT virus in Hungary: sequence heterogeneity and mixed infections. FEMS Immunol Med Microbiol35, 153-157 (2003).

    'TT virus in Hungary: sequence heterogeneity and mixed infections ' () 35 FEMS Immunol Med Microbiol : 153 -157.

    • Search Google Scholar
  • Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., Wollman, J.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology1, 431-435 (1981).

    'Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis ' () 1 Hepatology : 431 -435.

    • Search Google Scholar
  • Di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., Alter H. J.: Long term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology14, 969-974 (1991).

    'Long term clinical and histopathological follow-up of chronic posttransfusion hepatitis ' () 14 Hepatology : 969 -974.

    • Search Google Scholar
  • Pár, A., Paál, M., Horányi, M., Pár, G., Szekeres Bartho, J., Hegedüs, G., Gasztonyi, B., Mózsik, Gy.: Role of viral and host factors in the pathogenesis of hepatitis C virus infection and in the response to interferon treatment. Period Biol100, 515-519 (1998).

    'Role of viral and host factors in the pathogenesis of hepatitis C virus infection and in the response to interferon treatment ' () 100 Period Biol : 515 -519.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 0 0 0
May 2021 2 0 0
Jun 2021 0 0 0
Jul 2021 1 0 0
Aug 2021 5 0 0
Sep 2021 1 0 0
Oct 2021 0 0 0